Gregory J. Walker

3.0k total citations
25 papers, 382 citations indexed

About

Gregory J. Walker is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Gregory J. Walker has authored 25 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 10 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Gregory J. Walker's work include Respiratory viral infections research (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and SARS-CoV-2 detection and testing (5 papers). Gregory J. Walker is often cited by papers focused on Respiratory viral infections research (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and SARS-CoV-2 detection and testing (5 papers). Gregory J. Walker collaborates with scholars based in Australia, United States and Kenya. Gregory J. Walker's co-authors include William D. Rawlinson, Sacha Stelzer‐Braid, Alexander Pitman, Samuel Gledhill, Stuart Turville, Alberto Ospina Stella, Joshua R. Peterson, Padmavathy Bakthavathsalam, J. Justin Gooding and Yan Hang and has published in prestigious journals such as Nature Biotechnology, Analytical Chemistry and PEDIATRICS.

In The Last Decade

Gregory J. Walker

22 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory J. Walker Australia 11 131 129 70 63 49 25 382
Ko‐Yung Sit Hong Kong 6 492 3.8× 145 1.1× 41 0.6× 87 1.4× 65 1.3× 12 671
Carlos Capela Portugal 7 196 1.5× 81 0.6× 14 0.2× 62 1.0× 58 1.2× 18 393
Guanjing Lang China 10 92 0.7× 57 0.4× 49 0.7× 29 0.5× 49 1.0× 18 269
Martin L. Watzenboeck Austria 8 38 0.3× 39 0.3× 35 0.5× 107 1.7× 67 1.4× 17 342
David M. Manthei United States 11 236 1.8× 62 0.5× 10 0.1× 50 0.8× 40 0.8× 31 442
Alexander Wood United Kingdom 13 101 0.8× 99 0.8× 22 0.3× 78 1.2× 148 3.0× 19 545
Qingqing Lin China 4 490 3.7× 37 0.3× 26 0.4× 91 1.4× 18 0.4× 11 584
Liting Yan China 7 470 3.6× 73 0.6× 71 1.0× 90 1.4× 58 1.2× 18 613
Ke Hong China 9 338 2.6× 39 0.3× 14 0.2× 55 0.9× 33 0.7× 15 457
Sandra Hauka Germany 5 406 3.1× 35 0.3× 22 0.3× 61 1.0× 12 0.2× 7 473

Countries citing papers authored by Gregory J. Walker

Since Specialization
Citations

This map shows the geographic impact of Gregory J. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Walker more than expected).

Fields of papers citing papers by Gregory J. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory J. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Walker. The network helps show where Gregory J. Walker may publish in the future.

Co-authorship network of co-authors of Gregory J. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory J. Walker. A scholar is included among the top collaborators of Gregory J. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory J. Walker. Gregory J. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foster, Charles S. P., Gregory J. Walker, Sonia R. Isaacs, et al.. (2025). Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution. Journal of Virology. 99(7). e0036325–e0036325.
2.
3.
Bartlett, Adam, et al.. (2024). Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development. Reviews in Medical Virology. 34(5). e2576–e2576. 8 indexed citations
4.
Kim, Ki Wook, et al.. (2024). Genome characterization of influenza A and B viruses in New South Wales, Australia, in 2019: A retrospective study using high‐throughput whole genome sequencing. Influenza and Other Respiratory Viruses. 18(1). e13252–e13252. 5 indexed citations
5.
Rodrigo, Chaturaka, Gregory J. Walker, Chelsea Nguyen, et al.. (2024). Acute Q fever in patients with an influenza-like illness in regional New South Wales, Australia. PLoS neglected tropical diseases. 18(8). e0012385–e0012385.
6.
Walker, Gregory J., et al.. (2024). The resurgence of influenza A/H3N2 virus in Australia after the relaxation of COVID‐19 restrictions during the 2022 season. Journal of Medical Virology. 96(9). e29922–e29922. 4 indexed citations
7.
Horsburgh, Bethany A., Gregory J. Walker, Anthony D. Kelleher, et al.. (2024). Next‐Generation Sequencing Methods for Near‐Real‐Time Molecular Epidemiology of HIV and HCV. Reviews in Medical Virology. 34(6). e70001–e70001. 1 indexed citations
8.
Walker, Gregory J., Charles S. P. Foster, Ana Domazetovska, et al.. (2024). Clinical, Genomic, and Immunological Characterization of RSV Surge in Sydney, Australia, 2022. PEDIATRICS. 153(2). 13 indexed citations
9.
Chen, Xueqian, Gregory J. Walker, Sacha Stelzer‐Braid, et al.. (2023). Machine Learning Color Feature Analysis of a High Throughput Nanoparticle Conjugate Sensing Assay. Analytical Chemistry. 95(16). 6550–6558. 6 indexed citations
10.
Foster, Charles S. P., Rowena A. Bull, Nicodemus Tedla, et al.. (2023). Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak. Viruses. 15(2). 522–522. 5 indexed citations
11.
Giallonardo, Francesca Di, Anupriya Aggarwal, Alberto Ospina Stella, et al.. (2023). Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2. Antiviral Research. 217. 105677–105677. 15 indexed citations
12.
Walker, Gregory J., et al.. (2022). Simultaneous monitoring of eight human respiratory viruses including SARS-CoV-2 using liquid chromatography-tandem mass spectrometry. Scientific Reports. 12(1). 13392–13392. 1 indexed citations
13.
Rouet, Romain, Ohan Mazigi, Gregory J. Walker, et al.. (2021). Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies. mAbs. 13(1). 1922134–1922134. 15 indexed citations
14.
Walker, Gregory J., Vanessa Clifford, Nidhi Bansal, et al.. (2020). SARS‐CoV ‐2 in human milk is inactivated by Holder pasteurisation but not cold storage. Journal of Paediatrics and Child Health. 56(12). 1872–1874. 33 indexed citations
15.
Bockel, David van, C. Mee Ling Munier, Stuart Turville, et al.. (2020). Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing. Viruses. 12(11). 1208–1208. 29 indexed citations
16.
17.
Walker, Gregory J., Padmavathy Bakthavathsalam, Joshua R. Peterson, et al.. (2018). Systematic review of the impact of point‐of‐care testing for influenza on the outcomes of patients with acute respiratory tract infection. Reviews in Medical Virology. 28(5). e1995–e1995. 61 indexed citations
18.
Walker, Gregory J., et al.. (2016). Reference Range for Intrapatient Variability in Blood-Pool and Liver SUV for 18F-FDG PET. 7 indexed citations
19.
Walker, Gregory J., et al.. (2013). Reference Range for Intrapatient Variability in Blood-Pool and Liver SUV for 18F-FDG PET. Journal of Nuclear Medicine. 54(5). 677–682. 68 indexed citations
20.
Pechhold, Susanne, Melissa A. Stouffer, Gregory J. Walker, et al.. (2009). Transcriptional analysis of intracytoplasmically stained, FACS-purified cells by high-throughput, quantitative nuclease protection. Nature Biotechnology. 27(11). 1038–1042. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ko‐Yung Sit Breakdown of academic impact, for papers by Carlos Capela Breakdown of academic impact, for papers by Guanjing Lang Breakdown of academic impact, for papers by Martin L. Watzenboeck Breakdown of academic impact, for papers by David M. Manthei Breakdown of academic impact, for papers by Alexander Wood Breakdown of academic impact, for papers by Qingqing Lin Breakdown of academic impact, for papers by Liting Yan Breakdown of academic impact, for papers by Ke Hong Breakdown of academic impact, for papers by Sandra Hauka
Rankless by CCL
2026